typhoid vaccine
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / July 2009 / July 23, 2009
Vi typhoid vaccine protects young Indian children
RSS / Print / Comments

Health News

New study confirms smoking, cancer link (reissue)
Taking up smoking results in epigenetic changes associated with the development of cancer, UK scientists have reported. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Chemicals in mother's blood linked to child's obesity
A team of scientists has revealed that babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body ma*s index (BMI) by 14 months. ANI

Vi typhoid vaccine protects young Indian children

A currently available and yet unused typhoid vaccine has been found effective in protecting young children in India, according to researchers.

London, July 23 : A currently available and yet unused typhoid vaccine has been found effective in protecting young children in India, according to researchers.

The research team from National Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India and International Vaccine Institute (IVI), Korea showed that vaccine Vi polysaccharide is ideally suited to use in developing countries and can offer protection to almost 80pct of the children.

Multidrug-resistant Salmonella typhi has spread to many parts of the world, limiting the ability to treat typhoid fever with available antibiotics. Typhoid is both a waterborne and food-borne gastrointestinal infection.

The researchers revealed that despite a recommendation by the World Health Organization for use of Vi vaccines in developing countries, its use has been limited, partly because of doubts about Vi's ability to protect pre-school age children.

This age group is at exceptionally high risk in the poorest settings. There are also doubts about Vi's ability to confer "herd protection," or protection of unvaccinated residents living in highly vaccinated areas.uring the study, researchers looked at 80 geographic clusters of an urban Kolkata slum.

They were given either Vi or a control vaccine. Over two years of follow-up, the Vi group was shown to have 61 percent fewer episodes of typhoid than the control group.

The study showed that delivering the low-cost Vi typhoid vaccine is logistically and programmatically possible.

Protection of vaccinated children under five years of age by Vi was even higher with 80pct.

"The protection for children under the age of five years is important because this age group has been shown to be at high risk for typhoid fever in many areas where the disease is endemic," said Dr. John Clemens, Director-General of the IVI and an international expert in vaccine evaluation.

Since the coverage of residents of the Vi clusters was about 60percent, this observation indicates that Vi vaccine prevented as many cases of typhoid in the total population as a vaccine that was nearly 100 percent protective in vaccinated persons.

The study appears in New England Journal of Medicine.


Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook

© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us